Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Shows Positive Early Trial Results
Research showed the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (Pfizer-BioNTech) increases neutralizing antibody response against multiple variants of Omicron.A 30-µg booster...

                                                                        COVID-19 and myocarditis in competitive athletes | Medical News Bulletin                                
                                                                        Quick takes: Climate change impact, dengue in Bangladesh, hypervirulent recombinant coronavirus in cats                                
                                                                        After-action report finds that hepatitis A outbreak helped hone COVID-19 response – The San Diego Union-Tribune                                
                                                                        Ohio could drop below lowest COVID-19 cases in a year – NBC4 WCMH-TV                                
                                                                        The Search for Long Covid Treatments Takes a Promising Turn – WIRED